CTTC
Center for Technology Transfer & Commercialization
Being a part of the New Ventures ecosystem keeps participants informed of the cutting edge research and entrepreneurial activities in process throughout the Vanderbilt community.
Benefits for Industry:
• Opportunity to explore collaborative research and licensing arrangements powered by Vanderbilt technology. • Chance to explore strategic investment opportunities at early stages of development.
Benefits for Investors:
• Valuable source of deal flow and an opportunity to invest in spin-off and startup ventures. • Insight into research at Vanderbilt and an opportunity to explore licensing opportunities for your portfolio companies.
Information for PARTNERS Vanderbilt at a Glance
economic impact
endowment
$3.4B
$8.6B
sponsored research & project awards
• Perfect platform to offer services to Vanderbilt-related new ventures at reduced rates. • Access to a broader network through our ecosystem.
The New Ventures Team actively engages with experts within the community to work with us on various aspects of new venture creation process. Our ecosystem offers students, faculty, alumni and Vanderbilt related startups an opportunity to receive one-on-one mentoring with highly experienced entrepreneurs and executives with a wealth of experience in new venture development and a demonstrated history of innovation in high growth industries.
In 2013, the New Ventures Team assisted in the development of a business model and plan, as well as the transfer of intellectual property, to support InvisionHeart, LLC, a startup company based on a wireless ECG system (pictured below) developed by Franz Baudenbacher, Ph.D., and Susan Eagle, M.D., a Vanderbilt professor of engineering and anesthesiologist, respectively. An exclusive option was signed in April 2013 with Nashville entrepreneur Josh Nickols, Ph.D. In the spring of 2013, InvisionHeart was one of 10 companies selected to participate in the JumpStart Foundry Class of 2013, a 14-week startup accelerator program. It also won the 2013 Tech Venture Challenge, a competition that challenges Vanderbilt students to develop and present commercialization plans for Vanderbilt-powered technologies.
$550M
$572M
Benefits for Service Providers:
Benefits for Mentors:
total research expenditure
Vanderbilt Startups:
Total Investments:
Local Jobs Created:
65+ $400M+ 200+
CTTC
Information for PARTNERS
Center for Technology Transfer & Commercialization
Engaging Partners New ventures formed to commercialize technology developed at Vanderbilt have a positive impact at Vanderbilt and in our community. They contribute to the growth and diversification of the high-tech and life sciences industry in the region, create high-quality employment opportunities, promote entrepreneurship and fund additional research at Vanderbilt. What are some things that CTTC does to enhance the chances for new venture success? • We launch a few strategically-selected companies, focusing on quality versus quantity. • We connect new ventures with the right people who can help the new venture thrive. • New venture opportunities are vetted internally and by external advisors before launching. • In transactions with new ventures, time is of the essence. Our process is built to operate at the speed of business. • CTTC has professionals on staff who are exclusively dedicated to new venture creation. • We connect with investors to advance business opportunities for our portfolio technologies. Technology is important, but our new venture model is business-centric. • Vanderbilt will participate in corporate governance role only so long as our role can add value. • We accommodate the transactional needs of new ventures. Our business approach is flexible. Improving the probability of a new venture’s success is a priority that demands attention to all of the critical components. CTTC provides professional support to help optimize that outcome.
For more information contact:
CTTC owns equity in a diverse group of companies that span a range of technologies including computerized surgical navigation, natural products for insect control, clinical information management systems, clinical diagnostics, drug discovery, radiation therapy, and healthcare services - all of which are powered by Vanderbilt technologies. The Center’s active portfolio currently includes, (non-exhaustive list): Acuitec Solutions for high-acuity care
*Disciplina Advisors Investment management
*Aerovalve Pneumatic valves for energy reduction
*EndoInSight Colorectal cancer screening tool
American Sentinel University Distance learning *Annamometer Medical diagnostics
*FemtoMetrix Semiconductor materials Immunonet Biosciences Human genetics diagnostics
Molecular Sensing Illuminating biological interactions *NanoFerix Drug delivery system NephroGenex Renal disease diagnostics and therapeutics
Neurotargeting Informatics Corporation of America Medical image analysis and Clinical IT systems computer assisted solutions International FemtoScience, Inc. Pathfinder Therapeutics Appliflex Research & development for Image-guided surgical Laser vapor deposition for OLED advanced technology navigation for soft tissue manufacturing *InvisionHeart TyraTech (TYR.L) AssistMed Mobile ECG solution Natural insect control products Clinical IT solutions KaiNexus Universal Robotics *BioNanovations CQI software and services Robotics solutions Medical devices infused with bionanotechnology LifeWings *Wavefront Crew training for healthcare Drug Discovery Tools Cardiovascular Care Affiliates Healthcare services *LVR Technology Zirus Low Vision Readers Drug development for Cumberland Emerging Technologies infectious disease Life sciences business incubation Microarrays Assay services and products Diatech Oncology Personalize cancer therapy Apogee Informatics Healthcare data consultant
Peter Rousos Director, Economic & New Venture Development 615.343.4465 peter.c.rousos@vanderbilt.edu
*formed in the last two years
Rigved Joshi Manager, New Ventures 615.322.5477 rigved.joshi@vanderbilt.edu
Visit us online at www.vanderbilt.edu/cttc